Prognostic value of ultra-low PSA after 3 and 6 months of intensified androgen deprivation therapy in patients with metastatic castration-sensitive prostate cancer: Real-world data from a single healthcare center in Caracas, Venezuela

Authors

• Guillermo Borga
• Oscar Antonio Sucre Astorga, Advocate Health - MidwestFollow
• Santiago Sucre
• Carlos Eduardo Sucre
• Carbelis Larez

Recommended Citation

Borga G, Sucre Astorga OA, Sucre S, Sucre CE, Larez C. Prognostic value of ultra-low PSA after 3 and 6 months of intensified androgen deprivation therapy in patients with metastatic castration-sensitive prostate cancer: Real-world data from a single healthcare center in Caracas, Venezuela. Journal of Clinical Oncology. 2026/06/01 2026;44(16_suppl):e17110-e17110. doi:10.1200/JCO.2026.44.16_suppl.e17110

Affiliations

Advocate Lutheran General Hospital

Type

Abstract